US$ 25.98
obesity drug news today glp-1 september 29 2025 Weight-Loss Drugs Ride Health, Wellness Wave 2024 was a record year
Description
Is it easier in your life to take a once-weekly injection or a once-daily pill

[DOI] [PubMed] [Google Scholar] 16.Sivalingam S, Wasehuus VS, RotbainCurovic V, et al

Sebastian Povlsen, Department of Gastroenterology, Guys and St Thomas NHS Foundation Trust, London, United Kingdom

Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist that works through similar but expanded mechanisms

Acknowledgements Nil
Changes in vision should be evaluated, particularly in patients with pre-existing diabetic retinopathy
